Nanowerk Biotechnology News 2024-12-18

With models like AlphaFold3 limited to academic research, the team built an equivalent alternative, to encourage innovation more broadly.

This breakthrough marks a significant step toward potential next-generation treatments for neurological diseases like Alzheimer's and Parkinson's.